Key Insights
The Australian medicinal cannabis testing market is experiencing robust growth, projected to reach a market size of $112.39 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 20.10% from 2025 to 2033. This expansion is driven by several factors. Firstly, the increasing legalization and acceptance of medicinal cannabis within Australia fuels demand for rigorous testing to ensure product quality, safety, and compliance with stringent regulations. Secondly, advancements in analytical techniques and technologies offer more accurate and efficient testing methods, leading to improved product development and quicker turnaround times. Furthermore, growing awareness among patients and healthcare professionals about the therapeutic benefits of cannabis is a key market driver. The expanding research and development activities within the Australian medicinal cannabis sector contribute further to the market's expansion, as new products and formulations require comprehensive testing.
Major players such as ACS Laboratories, Agilent Technologies, and Thermo Fisher Scientific are shaping the market landscape through their advanced testing services and instrumentation. However, the market also faces challenges. These include the need for standardized testing protocols across the country, the high costs associated with advanced testing equipment and skilled personnel, and potential regulatory hurdles related to cannabis cultivation and product approval. Despite these restraints, the long-term outlook for the Australian medicinal cannabis testing market remains positive, fueled by increasing demand, technological innovation, and a growing regulatory framework that supports the industry's sustainable development. The market segmentation, while not explicitly provided, is likely to include categories based on testing methods (e.g., HPLC, GC-MS), types of cannabis products tested (e.g., oils, flowers, edibles), and geographical location within Australia.

Australia Medicinal Cannabis Testing Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the burgeoning Australia Medicinal Cannabis Testing Market, encompassing historical data (2019-2024), current estimations (2025), and future projections (2025-2033). It delves into market dynamics, growth trends, key players, and emerging opportunities within this rapidly evolving sector. The report serves as an indispensable resource for industry professionals, investors, and researchers seeking to understand and capitalize on the growth potential of the Australian medicinal cannabis testing landscape. The market is segmented by testing type (e.g., potency, pesticides, heavy metals) and end-users (e.g., cultivators, pharmaceutical companies). The total market size is projected to reach xx Million by 2033.
Australia Medicinal Cannabis Testing Market Dynamics & Structure
The Australian medicinal cannabis testing market is characterized by a moderately concentrated landscape with several key players vying for market share. Technological innovation, particularly in analytical techniques like HPLC and GC-MS, is a crucial driver. The regulatory framework, while evolving, continues to shape market access and testing requirements. Competitive substitutes, such as alternative analytical methods, exert limited pressure. End-user demographics predominantly comprise licensed cultivators and pharmaceutical companies. M&A activity has been relatively low in recent years, with xx deals recorded between 2019 and 2024, accounting for a xx% market share shift.
- Market Concentration: Moderately concentrated, with top 5 players holding approximately xx% market share.
- Technological Innovation: Driven by advancements in HPLC, GC-MS, and other analytical techniques.
- Regulatory Framework: Evolving, influencing market access and testing standards.
- Competitive Substitutes: Limited impact from alternative analytical methods.
- End-User Demographics: Primarily licensed cultivators and pharmaceutical companies.
- M&A Activity: Relatively low, with xx deals recorded between 2019 and 2024. Innovation barriers include high capital investment requirements for advanced testing equipment and the need for skilled personnel.
Australia Medicinal Cannabis Testing Market Growth Trends & Insights
The Australian medicinal cannabis testing market has witnessed substantial growth since its inception, driven by the increasing legalization and acceptance of medical cannabis. From a market size of xx Million in 2019, it is estimated to reach xx Million in 2025, demonstrating a CAGR of xx% during the historical period (2019-2024). This robust expansion is fueled by the rising demand for high-quality, compliant medical cannabis products and stringent regulatory requirements for testing. Technological advancements, particularly in faster and more precise testing methods, are further accelerating market growth. Consumer behavior is shifting towards greater awareness of product quality and safety, enhancing demand for thorough testing services. Market penetration of advanced testing technologies remains relatively low, indicating significant growth potential.

Dominant Regions, Countries, or Segments in Australia Medicinal Cannabis Testing Market
New South Wales and Victoria currently dominate the Australian medicinal cannabis testing market, driven by higher concentrations of licensed cultivators and research institutions. The favorable regulatory environment in these states, coupled with substantial investments in infrastructure, facilitates market growth. Other states are gradually catching up, but NSW and Victoria retain a significant advantage in terms of market share and growth potential.
- NSW & Victoria: Leading regions due to high cultivator concentration, supportive regulations, and infrastructure development.
- Other States: Exhibiting increasing growth, but lagging behind NSW and Victoria.
- Key Drivers: Supportive government policies, investments in infrastructure, and high demand for quality-assured cannabis products.
Australia Medicinal Cannabis Testing Market Product Landscape
The market offers a range of testing services, including potency analysis (THC, CBD), pesticide residue screening, heavy metal detection, and microbial testing. Innovations focus on improving speed, accuracy, and cost-effectiveness. Unique selling propositions include rapid turnaround times, high analytical sensitivity, and comprehensive reporting. Technological advancements include the integration of automation and AI in testing processes.
Key Drivers, Barriers & Challenges in Australia Medicinal Cannabis Testing Market
Key Drivers: Increasing legalization and acceptance of medicinal cannabis, stringent regulatory requirements, growing demand for quality-assured products, and technological advancements in testing methodologies.
Challenges: High capital investment for advanced equipment, scarcity of skilled personnel, regulatory uncertainties, and intense competition among testing laboratories. This competition is estimated to put pressure on profit margins, potentially impacting the growth by xx% by 2033. Supply chain bottlenecks related to specialized reagents and equipment could also affect growth.
Emerging Opportunities in Australia Medicinal Cannabis Testing Market
Emerging opportunities include the expansion into new testing areas (e.g., terpene profiling), the development of faster and more cost-effective testing methods, and the application of AI and machine learning in data analysis. The increasing demand for personalized medicine and the potential for cannabis-based therapeutics open up new avenues for growth.
Growth Accelerators in the Australia Medicinal Cannabis Testing Market Industry
Technological advancements like rapid testing platforms and AI-driven data analysis are accelerating market growth. Strategic partnerships between testing labs and cultivators/pharmaceutical companies enhance market reach and efficiency. Expansion into new states and territories and diversification of services are key growth catalysts.
Key Players Shaping the Australia Medicinal Cannabis Testing Market Market
- ACS Laboratories
- Agilent Technologies Inc
- Hamilton Company
- Merck KGaA
- PerkinElmer Inc
- Quantum Analytics
- Shimadzu Scientific Instruments
- Thermo Fisher Scientific
- Eurofins Scientific
- Pharmalytics
Notable Milestones in Australia Medicinal Cannabis Testing Market Sector
- June 2024: Tilray Medical launched Broken Coast EU-GMP-certified medical cannabis products, boosting demand for compliant testing.
- October 2023: Victoria’s Transport Legislation Amendment Bill 2023 enabled studies on medicinal cannabis and road safety, potentially driving further research and testing.
- February 2023: Launch of the CraftPlant medical cannabis brand by Aurora Cannabis and MedReleaf Australia increased market competition and the need for testing.
In-Depth Australia Medicinal Cannabis Testing Market Market Outlook
The Australian medicinal cannabis testing market is poised for significant growth, driven by continued legalization, technological innovations, and increasing consumer demand for safe and high-quality products. Strategic partnerships, expansion into new testing areas, and the adoption of advanced technologies will shape the market's future, presenting lucrative opportunities for both established and emerging players. The market is predicted to show considerable growth potential, propelled by these factors, reaching xx Million by 2033.
Australia Medicinal Cannabis Testing Market Segmentation
-
1. Product and Software/Service
- 1.1. Analytical Instruments
- 1.2. Spectroscopy Instruments
- 1.3. Consumables
- 1.4. Cannabis Testing Software and Services
-
2. Service
- 2.1. Potency Testing
- 2.2. Terpene Profiling
- 2.3. Residual Solvent Screening
- 2.4. Heavy Metal Testing
- 2.5. Mycotoxin Testing
- 2.6. Other Types
-
3. End User
- 3.1. Laboratories
- 3.2. Cannabis Drug Manufacturers and Dispensaries
- 3.3. Other End Users
Australia Medicinal Cannabis Testing Market Segmentation By Geography
- 1. Australia

Australia Medicinal Cannabis Testing Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 20.10% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rise in Approvals for Medicinal Cannabis; Increase in Cannabis-based Prescription by Healthcare Practisioners; Growing Prevalence of Chronic Pain
- 3.3. Market Restrains
- 3.3.1. Rise in Approvals for Medicinal Cannabis; Increase in Cannabis-based Prescription by Healthcare Practisioners; Growing Prevalence of Chronic Pain
- 3.4. Market Trends
- 3.4.1. The Potency Testing Segment is Anticipated to Hold a Major Share of the Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Australia Medicinal Cannabis Testing Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product and Software/Service
- 5.1.1. Analytical Instruments
- 5.1.2. Spectroscopy Instruments
- 5.1.3. Consumables
- 5.1.4. Cannabis Testing Software and Services
- 5.2. Market Analysis, Insights and Forecast - by Service
- 5.2.1. Potency Testing
- 5.2.2. Terpene Profiling
- 5.2.3. Residual Solvent Screening
- 5.2.4. Heavy Metal Testing
- 5.2.5. Mycotoxin Testing
- 5.2.6. Other Types
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Laboratories
- 5.3.2. Cannabis Drug Manufacturers and Dispensaries
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. Australia
- 5.1. Market Analysis, Insights and Forecast - by Product and Software/Service
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 ACS laboratories
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Agilent Technologies Inc
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Hamilton Company
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Merck KGaA
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 PerkinElmer Inc
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Quantum Analytics
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Shimadzu Scientific Instruments
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Thermo Fisher Scientific
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Eurofins Scientific
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Pharmalytics*List Not Exhaustive
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 ACS laboratories
List of Figures
- Figure 1: Australia Medicinal Cannabis Testing Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Australia Medicinal Cannabis Testing Market Share (%) by Company 2024
List of Tables
- Table 1: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Region 2019 & 2032
- Table 3: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Product and Software/Service 2019 & 2032
- Table 4: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Product and Software/Service 2019 & 2032
- Table 5: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Service 2019 & 2032
- Table 6: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Service 2019 & 2032
- Table 7: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by End User 2019 & 2032
- Table 8: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by End User 2019 & 2032
- Table 9: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Region 2019 & 2032
- Table 11: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Product and Software/Service 2019 & 2032
- Table 12: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Product and Software/Service 2019 & 2032
- Table 13: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Service 2019 & 2032
- Table 14: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Service 2019 & 2032
- Table 15: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by End User 2019 & 2032
- Table 16: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by End User 2019 & 2032
- Table 17: Australia Medicinal Cannabis Testing Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Australia Medicinal Cannabis Testing Market Volume Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Australia Medicinal Cannabis Testing Market?
The projected CAGR is approximately 20.10%.
2. Which companies are prominent players in the Australia Medicinal Cannabis Testing Market?
Key companies in the market include ACS laboratories, Agilent Technologies Inc, Hamilton Company, Merck KGaA, PerkinElmer Inc, Quantum Analytics, Shimadzu Scientific Instruments, Thermo Fisher Scientific, Eurofins Scientific, Pharmalytics*List Not Exhaustive.
3. What are the main segments of the Australia Medicinal Cannabis Testing Market?
The market segments include Product and Software/Service, Service, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 112.39 Million as of 2022.
5. What are some drivers contributing to market growth?
Rise in Approvals for Medicinal Cannabis; Increase in Cannabis-based Prescription by Healthcare Practisioners; Growing Prevalence of Chronic Pain.
6. What are the notable trends driving market growth?
The Potency Testing Segment is Anticipated to Hold a Major Share of the Market.
7. Are there any restraints impacting market growth?
Rise in Approvals for Medicinal Cannabis; Increase in Cannabis-based Prescription by Healthcare Practisioners; Growing Prevalence of Chronic Pain.
8. Can you provide examples of recent developments in the market?
June 2024: Tilray Medical, a division of Tilray Brands Inc. and a global leader in medical cannabis, launched Broken Coast EU-GMP-certified medical cannabis products in Australia.October 2023: Victoria’s Transport Legislation Amendment Bill 2023 amended nine Acts, including the Road Safety Act 1986. This amendment allows a study of medicinal cannabis and road safety and is sufficiently broad to enable the state government to conduct similar studies in relation to other drugs.February 2023: Aurora Cannabis Inc., the Canadian company, and MedReleaf Australia launched a new medical cannabis brand, CraftPlant, for patients in the Australian market.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Australia Medicinal Cannabis Testing Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Australia Medicinal Cannabis Testing Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Australia Medicinal Cannabis Testing Market?
To stay informed about further developments, trends, and reports in the Australia Medicinal Cannabis Testing Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence